ELI LILLY AND COMPAN

LLY
Delayed Quote. Delayed  - 06/11 04:10:00 pm
224.09USD -4.05%
Upcoming events on ELI LILLY AND COMPANY
06/18/21 | 11:00am Guggenheim Biopharma Strategy Series Conference
07/01/21 | 10:00am ADA Meeting
08/03/21 Interim 2021 Earnings Release
08/03/21 | 09:00am Interim 2021 Earnings Call

Past events on ELI LILLY AND COMPANY
06/09/21 | 08:50amGoldman Sachs Global Healthcare Conference
06/04/21 | 01:00pmAmerican Society of Clinical Oncology Conference - Abstract No - 9005
06/04/21 | 09:00amAmerican Society of Clinical Oncology Conference - Abstract No - 11517
06/04/21American Society of Clinical Oncology Conference - Abstract No - e18516

Upcoming sector events for ELI LILLY AND COMPANY
06/14/21 | 09:00am TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Annual General Meeting
06/14/21 ROCHE HOLDING AG : Bank of America Securities Napa Biopharma Virtual Conference
06/14/21 ASTRAZENECA PLC : Bank of America Securities Napa Biopharma Virtual Conference
06/15/21 | 03:30pm BRIDGEBIO PHARMA, INC. : Bank of America Securities Napa Biopharma Virtual Conference

Past sector events for ELI LILLY AND COMPANY
06/13/21 | 12:41pmJAZZ PHARMACEUTICALS PLC : SLEEP Meeting - Abstract #500
06/13/21SWEDISH ORPHAN BIOVITRUM AB (PUBL) : European hematology association congress - abstract code: ep1151
06/13/21SWEDISH ORPHAN BIOVITRUM AB (PUBL) : European Hematology Association Congress - Abstract #EP1144
06/13/21SWEDISH ORPHAN BIOVITRUM AB (PUBL) : European hematology association congress - abstract code: ep1148

Annual results
Previous yearNext Year
Annual results20202021 (e)
Sales
M $
Released
Forecast
Spread
24 540
24 394
0,60%

27 273
Operating income
(EBITDA)
M $
Released
Forecast
Spread
8 589
8 676
-1,0%

9 390
Operating profit
(EBIT)
M $
Released
Forecast
Spread
7 265
7 503
-3,2%

8 274
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
7 230
7 041
2,7%

7 473
Net income
M $
Released
Forecast
Spread
6 194
5 805
6,7%

6 537
EPS
$
Released
Forecast
Spread
6,79
6,36
6,7%

7,28
Announcement Date01/29/2021


Quarterly / Semiannualy publications
Previous periodNext period
Quarterly results2021 Q12021 Q2 (e)
Sales
M $
Released
Forecast
Spread
6 806
6 960
-2,2%

6 624
Operating income
(EBITDA)
M $
Released
Forecast
Spread

2 757

2 275
Operating profit
(EBIT)
M $
Released
Forecast
Spread
1 873
2 323
-19%

2 010
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
1 476
2 178
-32%


Net income
M $
Released
Forecast
Spread
1 355
1 851
-27%


EPS
$
Released
Forecast
Spread
1,49
2,04
-27%

1,66
Announcement Date04/27/2021

Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise